Surgical perspective on invasive Candida infections

World Journal of Surgery

Volumn 22, Issue 2, 1998, Pages 127-134

  Dean, David A ^a   Burchard, Kenneth W ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; DIPHENHYDRAMINE; FLUCONAZOLE; KETOCONAZOLE; NYSTATIN; PARACETAMOL; PETHIDINE; PLACEBO; PSEUDOMONIC ACID;

ANEMIA; CANDIDIASIS; CHILL; CLINICAL TRIAL; CRITICAL ILLNESS; DEBRIDEMENT; DRUG CHOICE; FEVER; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; INTENSIVE CARE UNIT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; INTRAVESICAL DRUG ADMINISTRATION; LIVER TOXICITY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PROPHYLAXIS; REVIEW; RISK FACTOR; SURGICAL DRAINAGE; SURGICAL PATIENT; TOPICAL DRUG ADMINISTRATION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BURNS; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; FUNGEMIA; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 0031908429     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900360     Document Type: Review

References (84)

1. Krause, W., Matheis, H., Wulf, K.: Fungemia and funguria after oral administration of Candida albicans. Lancet 1:598, 1969
2. Hickey, W.F., Sommerville, L.H., Schoen, F.J.: Disseminated Candida glabrata: a report of a uniquely severe infection and a literature review. Am. J. Clin. Pathol. 80:724, 1983
3. Parker, J.C., McClosky, J.J., Knauer, K.A.: Pathologic features of human candidiasis: a common deep mycosis of the brain, heart, and kidney in the altered host. Am. J. Clin. Pathol. 65:991, 1976
4. Horan, T., Culver, D., Jarvis, W.: Pathogens causing nosocomial infections: preliminary data from the national nosocomial infections surveillance system. Antimicrob. Newslett. 5:1, 1988
5. Banerjee, S.N., Emori, T.G., Culver, D.H., Gaynes, R.P., Jarvis, W.R., Horan, T., Edwards, J.R., Tolson, J., Henderson, T., Martone, W.J.: Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am. J. Med. 91(Suppl. 3B):86S, 1989
6. Beck-Sague, C.M., Jarvis, W.R., System, t.N.N.I.S.: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247, 1993
7. Wey, S.B., Mori, M., Pfaller, M.A.: Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 145:2642, 1988
8. Fraser, V.J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., Dunagan, W.C.: Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414, 1992
9. Burchard, K.W., Minor, L.B., Slotman, G.J., Gann, D.S.: Fungal sepsis in surgical patients. Arch. Surg. 118:217, 1983
10. Dyess, D.L., Garrison, R.N., Fry, D.E.: Candida sepsis: implications of polymicrobial blood-borne infection. Arch. Surg. 120:345, 1985
11. Eubanks, P.J., Virgilio, C.D., Klein, S., Bongard, F.: Candida sepsis in surgical patients. Am. J. Surg. 166:617, 1993
12. Wey, S.B., Mori, M., Pfaller, M.A., Woolson, R.F., Wenzel, R.P.: Risk factors for hospital-acquired candidemia: a matched case-control study. Arch. Intern. Med. 149:2349, 1989
13. Wittmann, D.H., Schein, M., Condon, R.E.: Management of secondary peritonitis. Ann. Surg. 224:10, 1996
14. Hughes, W.T.: Systemic candidiasis: a study of 109 fatal cases. Pediatr. Infect. Dis. 1:11, 1982
15. Horn, R., Wong, B., Kiehn, T.E., Armstrong, D.: Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev. Infect. Dis. 7:646, 1985
16. Wingard, J.R., Merz, W.G., Rinaldi, M.G., Johnson, T.R., Karp, J.E., Saral, R.: Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274, 1992
17. Komshian, S.V., Uwaydah, A.K., Sobel, J.D., Crane, L.R.: Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 2:379, 1989
18. Solomkin, J.S., Flohr, A.M., Simmons, R.L.: Indications for therapy for fungemia in postoperative patients. Arch. Surg. 117:1272, 1982
19. Gaines, J.D., Remington, J.S.: Disseminated candidiasis in surgical patients. Surgery 72:730, 1972
20. Geha, D.J., Roberts, G.T.: Laboratory detection of fungemia. Clin. Lab. Med. 14:83, 1994
21. Stone, H.H., Kolb. L.D., Currie, C.A., Geheber, C.E., Cuzzell, J.Z.: Candida sepsis: pathogenesis and principles of treatment. Ann. Surg. 179:697, 1974
22. Kujath, P., Lerch, K., Dammrich, J.: Fluconazole monitoring in Candida peritonitis based on histological control. Mycoses 33:441, 1990
23. Rutledge, R., Mandel, S.R., Wild, R.E.: Candida sepsis: insignificant contaminant or pathologic species. Am. Surg. 52:299, 1986
24. Ikeda, K., Yamashita, J., Fujisawa, H., Fujita, S.: Cerebral granuloma and meningitis caused by Candida albicans useful monitoring of mannan antigen in cerebrospinal fluid. Neurosurgery 26:860, 1990
25. Kozinn, P.J., Taschdjian, C.L., Kodsi, B.E., Wise, G.J., Seelig, M.S., Goldberg, P.K.: Diagnosis of systemic and visceral candidosis. Can. Med. Assoc. J. 126:1386, 1982
26. Podzorski, R.P., Herren, M.J., Fast, D.J., Nelson, R.D.: Pathogenesis of candidiasis. Arch. Surg. 124:1290, 1989
27. Walsh, T.J., Hathorn, J.W., Sobel, J.D., Merz, W.G., Sanchez, V., Maret, S.M., Buckley, H.R., Pfaller, M.A., Schaufele, R., Sliva, C.: Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 324:1026, 1991
28. Rosemurgy, A.S., Sweeney, J.F., Albrink, M.H., Wei, S., Djeu, J.Y.: Implications of Candida titers in injured adults. Contemp. Surg. 42:327, 1993
29. Cabezudo, I., Pfaller, M., Gerarden, T., Koontz, F., Wenzel, R., Gingrich, R., Heckman, K., Burns, C.P.: Value of the Cand-Tec Candida antigen assay in the diagnosis and therapy of systemic candidiasis in the high-risk patients. Eur. J. Clin. Microbiol. Infect. Dis. 8:770, 1989
30. Pfaller, M.A., Cabezudo, I., Buschelman, B., Bale, M., Howe, T., Vitug, M., Linton, H.J., Densel, M.: Value of the Hybritech ICON Candida assay in the diagnosis of invasive candidiasis in high-risk patients. Diagn. Microbiol. Infect. Dis. 16:53, 1993
31. Burchard, K.W.: Fungal sepsis. Infect. Dis. Clin. North Am. 6:677, 1992
32. Bodey, G.P., Lano, M.: Skin lesions associated with disseminated candidiasis. J.A.M.A. 222:1466, 1974
33. Jarowski, C.I., Fialk, M.A., Murray, H.H., Gottlieb, G.J., Coleman, M., Steinberg, C.R., Silver, R.T.: Fever, rash and muscle tenderness: a distinctive clinical presentation of disseminated candidiasis. Arch. Intern. Med. 138:544, 1978
34. Kressel, B., Szewczyk, C., Tuazon, C.V.: Early clinical resolution of disseminated candidiasis by muscle and skin biopsy. Arch. Intern. Med. 138:429, 1978
35. Donahue, S.P., Greven, C.M., Zuravleff, J.J., Eller, A.W., Nguyen, M.H., Peacock, J.E., Jr., Wagener, M.W., Yu, V.L.: Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology 101:1302, 1994
36. Slotman, G.J., Shapiro, E., Moffa, S.M.: Fungal sepsis: multisite colonization versus fungemia. Am. Surg. 60:107, 1994
37. Anaissie, E., Solomkin, J.S.: Fungal infection. In Meakins JL, ed. Surgical Infections: Diagnosis and Treatment (Vol. 1), J.L. Meakins, editor. New York, Scientific American, 1994
38. Brajtburg, J., Powderly, W.G., Kobayashi, G.S., Medoff, G.: Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother. 33:362, 1989
39. Solomkin, J.S., Flohr, A., Simmons, R.L.: Candida infections in surgical patients: dose requirements and toxicity of amphotericin B. Ann. Surg. 195:177, 1982
40. Craven, P.C., Ludden, T.M., Drutz, D.J., Rogers, W., Haegele, K.A., Skrdlant, H.B.: Excretion pathways of amphotericin B. J. Infect. Dis. 140:329, 1979
41. Brammer, K.W., Farrow, P.R., Falkner, J.K.: Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12(Suppl. 3):S318, 1990
42. Bodey, G.P.: Azole antifungal agents. Clin. Infect. Dis. 14(Suppl. 1):S161, 1992
43. Wingard, J.R., Merz, W.G., Rinaldi, M.G., Miller, C.B., Karp, J.E., Sarel, R.: Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow patients. Antimicrob. Agents Chemother. 37:1847, 1993
44. Rex, J.H., Bennett, J.E., Sugar, A.M., Pappas, P.G., van der Horst, C.M., Edwards, J.E., Washburn, R.G., Scheld, W.M., Kerchmer, A.W., Dine, A.P.: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325, 1994
45. Kujath, P., Lerch, K., Kcendorfer, P., Boos, C.: Comparative study of the efficacy of fluconazole versus amphotericin b/flucytosine in surgical patients with systemic mycoses. Infection 21:376, 1993
46. Isenberg, H.D., Pisano, M.A., Carito, S.L., Berkman, J.S.: Factors leading to overt monilial disease: preliminary studies on the ecological relationship between Candida albicans and intestinal bacteria. Antibiot. Chemother. 10:253, 1960
47. Kennedy, M.J., Volz, P.A.: Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by antagonism. Infect. Immun. 49:654, 1985
48. Samonis, G., Gikas, A., Toludis, P., Maraki, S., Vrentzos, G., Tselentis, Y., Tsaparas, N., Bodey, G.: Prospective study of the impact of broad-spectrum antibiotics on yeast flora of the human gut. Eur. J. Clin. Microbiol. Infect. Dis. 13:665, 1994
49. D'Amelio, L.F., Wagner, B., Azimeddin, S., Sutyak, J.D., Hammond, J.S.: Antibiotic patterns associated with fungal colonization in critically ill surgical patients. Am. Surg. 61:1049, 1995
50. Volkheimer, G., Schultz, F.H.: The phenomenon of persorption. Digestion 1:213, 1968
51. Marshall, J.C., Christos, N.V., Meakins, J.L.: The gastrointestinal tract: the "undrained abscess" of multiple organ failure. Ann. Surg. 218:111, 1993
52. McGinnis, M.R., Ajello, L., Beneke, E.S., Drouhet, E., Goodman, N.L., Halde, C.J., Haley, L.D., Kane, J., Land, G.A., Padhye, A.A.: Taxonomic and nomenclature evaluation of the genera Candida and Torulopsis. J. Clin. Microbiol. 20:813, 1984
53. Gogos, C.A.: Effect of different types of total parenteral nutrition on T-lymphocyte subpopulations and NK cells. Am. J. Clin. Nutr. 51:119, 1990
54. Hennessey, P.J., Black, C.T., Androgsy, R.J.: Glycosylation of immunoglobin G impairs complement fixation. J. Parenter. Ent. Nutr. 15:60, 1991
55. Palmbland, J.: Intravenous lipid emulsions and host defense: a critical review. Clin. Nutr. 10:303, 1991
56. Shou, J., Lappin, J., Daly, J.M.: Impairment of pulmonary macrophage function with total parenteral nutrition. Ann. Surg. 3:291, 1994
57. Alverdy, J., Aoys, E., Weiss-Carrington, P., Burk, D.A.: The effect of glutamine-enriched TPN on gut immune cellularity. J. Surg. Res. 52:34, 1992
58. Shou, J., Lappin, J., Minnard, E., Daly, J.M.: TPN, bacterial translocation and host immune function. Am. J. Surg. 167:145, 1994
59. Alverdy, J., Aoys, E., Moss, G.S.: Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 104:185, 1988
60. Plouffe, J.F., Brown, D.G., Silva, J., Eck, T., Stricof, R.L., Fekety, R.: Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch. Intern. Med. 137:1686, 1977
61. Alexander, J.W., Ogle, C.K., Stinnet, J.D., Macmillan, B.C.: A sequential prospective analysis of immunologic abnormalities and infection following severe thermal injury. Ann. Surg. 188:809, 1978
62. Bjerknes, R., Vindenes, H., Pitkanen, J., Ninnemann, J., Laerum, O.D., Abyholm, F.: Altered polymorphonuclear neutrophilic granulocyte functions in patients with large burns. J. Trauma 29:847, 1989
63. Bradley, J.A., Hamilton, D.N.H., Brown, M.W., Cance, W., Jackson, V.S., Ledingham, I.M.: Cellular defense in the critically ill surgical patient. Crit. Care Med. 12:565, 1984
64. McLoughlin, G.A., Wu, A.V., Saporoschetz, I., Nimberg, R., Mannick, J.A.: Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma. Ann. Surg. 190:297, 1979
65. Scovill, W.A., Saba, T.M.: Humoral recognition deficiency in etiology of reticuloendothelial depression induced by surgery. Ann. Surg. 178:59, 1973
66. Kirkpatrick, C.H.: Host factors in defense against fungal infection. Am. J. Infect. 77(Suppl. 4D):1, 1984
67. Diamond, R.D.: Immune response to fungal infection. Rev. Infect. Dis. 11(Suppl. 7):S1600, 1989
68. Schaffner, A., Davis, C.E., Schaffner, T., Markert, M., Douglas, H., Braude, A.I.: In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. J. Clin. Invest. 78:511, 1986
69. Pruitt, B.A., Jr., Goodwin, C.W., Pruitt, S.K.: Burns: including cold, chemical, and electrical injuries. In Textbook of Surgery: The Biological Basis of Modern Surgical Practice (14th ed)., D.C. Sabiston Jr., editor. Philadelphia, Saunders, 1991
70. + and T cells as assessed using anti-CD45R. Clin. Immunol. Immunopathol. 47:164, 1988
71. Gadd, M.A., Hansbrough, J.F., Hoyt, D.B., Ozkan, N.: Defective T-cell surface antigen expression after mitogen stimulation: an index of lymphocyte dysfunction after controlled murine injury. Ann. Surg. 209:112, 1989
72. Constantian, M.B.: Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients. Ann. Surg. 188:209, 1978
73. Savino, J.A., Agarwal, N., Wry, P., Policastro, A., Cerabona, T., Austria, L.: Routine prophylactic antifungal agents (clotrimazole, ketaconazole, and nystatin) in non transplant/non burned critically ill surgical and trauma patients. J. Trauma 36:20, 1994
74. Nassoura, Z., Ivatury, R.R., Simon, R.J., Jabhour, N., Stahl, W.M.: Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J. Trauma 35:290, 1993
75. Pittet, D., Monod, M., Suter, P.M., Frenk, E.: Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg. 220:751, 1994
76. Konnes, R.J., Cutitar, M., Burchard, K.W.: Perforated peptic ulcer, determinants of morbidity and mortality. Am. Surg. 56:280, 1990
77. Cornwell, E.E., III, Belzberg, H., Offne, T.V., Dougherty, W.R., Morales, I.R., Asensio, J., Demetrides, D.: The pattern of fungal infections in critically ill surgical patients. Am. Surg. 61:847, 1995
78. Slotman, G.J., Burchard, K.W.: Ketaconazole prevents Candida sepsis in critically ill surgical patients. Arch. Surg. 122:147, 1987
79. Goodman, J.L., Winston, D.J., Greenfield, R.A., Chandrasekar, P.H., Fox, B., Kaizer, H., Shadduck, R.K., Shea, T.C., Stiff, P., Friedman, D.J.: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 326:845, 1992
80. Stone, H.H.: Studies in the pathogenesis, diagnosis and treatment of Candida sepsis in children. J. Pediatr. Surg. 9:127, 1974
81. Degregorio, M.N., Lee, W.M., Reis, R.A.: Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 50:2780, 1982
82. Van Der Mer, J.W., Kewning, J.J., Scheijgrong, H.W., Heykants, J., Van Custen, J., Bregmans, J.: The influence of gastric acidity on the bioavailability of ketaconazole. J. Antimicrob. Chemother. 6:552, 1980
83. Bodey, G.P., Anaissie, E.J., Elting, L.S., Estey, E., O'Brien, S., Kantarjian, H.: Antifungal prophylaxis during remission therapy for acute leukemia, fluconazole versus amphotericin B. Cancer 73:2099, 1994
84. Vinsant, G.O., Todd, J., Fallon, W.: Reduction of Candida infections in the high risk trauma patient. Presented to the American College of Surgeons, San Francisco, 1993